Dividend Taxation Procedures
03.06.2015
Moscow, Russia – MD Medical Group Investments Plc (“MD Medical Group”,
“MDMG” or the “Company” – LSE: MDMG), Russia’s leading provider of private women’s
and children’s healthcare, today publishes information regarding dividend taxation procedures
under the Russian Tax Code
Back to news list
MD Medical Group has been a Russian tax resident since 1 January 2015, and pays dividends in
line with the Russian Tax Code.
Under the Russian Tax Code, dividends paid by Russian companies are generally subject to a tax
rate of 15%. A reduced rate may be applied in the case of Russian tax residents and residents of
foreign jurisdictions whose Governments have signed a double taxation treaty (“DTT”) with the
Government of Russia. Countries that have signed a DTT with Russia are listed in Appendix 1.
Terms for applying a reduced tax rate for certain countries are set out in Appendix 2. Information
regarding terms for other countries not included in the file is available on request from MDMG.
MD Medical Group acts as a tax agent and withholds tax in order to transfer it to the Russian tax
authorities when paying dividends.
Shareholders have the right to reclaim taxation withheld by the Company from the Russian tax
authorities, or to apply to MDMG for reduced tax rate treatment. Shareholders should provide
documents including but not limited to the following in order to apply for reduced tax rate
treatment:
1. Documents confirming ownership of shares or GDRs of the Company as of 5 June 2015
(the record date for eligibility to receive the dividend);
2. Certificate of tax residency (or other similar document);
3. Letter of guarantee confirming that that person is the beneficial recipient of the dividend;
4. Documents confirming the credentials of the signatory of the letter of guarantee.
More information about the conditions for applying the reduced rate of taxation and the requisite
documents is set out in Appendixes 2 and 3.
Originals of the documents confirming the right to receive reduced taxation rates on the
dividends should be sent to the Company no later than 26 June 2015. Scanned copies of the
relevant documents may be sent to the Company in the first instance to verify that the documents
are correct and sufficient to allow application of the reduced tax rates.
MD Medical Group reserves the right to demand any additional documents or information
necessary to confirm the right of an investor to receive the dividend with taxation applied at the
reduced rate.
In the event that the necessary documents or information are not provided on time or in full, the
Company in accordance with the Russian Tax Code is obliged to apply taxation at 15% when
paying the dividend. In this case shareholders have the right to apply independently to reclaim
taxation from the Russian tax authorities.
{file:press/appendix_1.pdf}
{file:press/appendix_2.pdf}
{file:press/appendix_3.pdf}
For further information please contact:
Investors | Media |
Elena Romanova | EM Moscow Tom Blackwell / Sergii Pershyn Tel: +7 495 363 2849 MDMG@em-comms.com |
Mikhail Melnikov
Head of Corporate Governance corp.legal@mcclinics.ru |
About MD Medical Group
MD Medical Group operates in the highly attractive Russian private healthcare service market
and has a leading position in high-quality women's health and paediatrics. The company
manages 23 modern healthcare facilities, including 4 hospitals and 19 outpatient clinics in
Moscow, St. Petersburg, Ufa, Perm, Samara and Samara region, Novosibirsk, Irkutsk, Yaroslavl
and Ryazan. In addition, 3 franchised outpatient clinics operate in Kyiv, Ukraine.
In 2014, there were 4,550 deliveries; IVF cycles amounted to 7,654. Number of outpatient
treatments totalled 818,636 and number of in-patient days reached 35,900.
The Company's shares have been listed on the London Stock Exchange (LSE ticker "MDMG")
in the form of Global Depositary Receipts (GDRs) since 12 October 2012.
Forward-Looking Statements:
This press release contains forward looking statements, which are based on the Company’s
current expectations and assumptions and may involve known and unknown risks and
uncertainties that could cause actual results, performance or events to differ materially from
those expressed or implied in such statements. The forward looking statements contained in this
press release are based on past trends or activities and should not be taken that such trends or
activities will continue in the future. It is believed that the expectations reflected in these
statements are reasonable, but they may be affected by a number of variables which could cause
actual results or trends to differ materially, including, but not limited to: conditions in the
market, market position of the Company, earnings, financial position, cash flows, return on
capital and operating margins, anticipated investments and economic conditions; the Company’s
ability to obtain capital/additional finance; a reduction in demand by customers; an increase in
competition; an unexpected decline in revenue or profitability; legislative, fiscal and regulatory
developments, including, but not limited to, changes in environmental and health and safety
regulations; exchange rate fluctuations; retention of senior management; the maintenance of
labour relations; fluctuations in the cost of input costs; and operating and financial restrictions as
a result of financing arrangements.
No statement in this press release is intended to constitute a profit forecast, nor should any statements be interpreted to mean that earnings or earnings per share will necessarily be greater or lesser than those for the relevant preceding financial periods for the Company. Each forward looking statement relates only as of the date of the particular statement.